Qiagen extends reach in Asia with S'pore JV
This article was originally published in Clinica
Executive Summary
Dutch sample and assay technologies specialist Qiagen and Bio*One Capital, Asia's largest healthcare venture capital firms, have formed a molecular diagnostics joint venture in Singapore.